The Hot Tort Report:
January 2025
The Hottest in Mass Tort Spending: December 2024
Featured Tort
Birth Control Injections
Subscribe to the Hot Tort Report
What’s the Tort News?
Published: January, 2025. TV spend from multiple sources for a recent 30 day period.
If you have any questions, please contact Bails at bails@whitehardt.com
#1 Mesothelioma – $1,827,000
The year ended with this tort’s third-lowest monthly spend for 2024, but Mesothelioma still dominates. Comprising a massive portion of the overall report and maintaining its position as a leader in mass tort advertising, it is outpacing the second-place contender more than threefold.
For metrics such as CPA, CPL, and criteria, please contact us.
#2 Takata Airbag Recall – $425,000
The Takata Airbag Recall tort continues to blaze ahead, with December TV ad spending soaring to more than four times October’s levels. The NHTSA reports approximately 67 million airbags have been recalled, underscoring the widespread nature of this issue. On the international front, Cyprus plans to begin recalls in February 2025, with at least three related fatalities in this small Mediterranean country. While this is a globally relevant concern, individuals right here in the U.S. are urgently seeking representation.
For metrics such as CPA, CPL, and criteria, please contact us.
#3 Birth Control Injections – $387,000
The Birth Control Injections tort is our featured tort, with December’s TV advertising spend surpassing the total from the previous three months combined. Since the British Medical Journal’s March 2024 revelation of a link between Depo-Provera and meningioma brain tumors, the need for skilled legal representation in these cases has only grown. Having entered our Hot Tort Report in September, this tort has shown consistent and significant growth, highlighting its continued importance in the mass tort landscape.
For metrics such as CPA, CPL, and criteria, please contact us.
#4 Talcum Powder – $227,000
Talcum Powder’s spending fired back up at the end of Q4, making its first appearance on the report since September TV ad spending was covered. This resurgence in advertising was driven in part by renewed public and regulatory scrutiny. At the end of December, the FDA proposed a rule to standardize asbestos testing in talc-containing cosmetic products, emphasizing the potential risks tied to contamination. As attention grows on the safety of these products, so too does the need for trusted litigators to address the harm caused by asbestos exposure.
CPL: $470
CPA: $940
For criteria, please contact us.
#5 Roundup® – $199,000
After two months of no activity, TV ad spending for Roundup® rebounded strongly in December, ranking it in the top five for the month. With glyphosate-based Roundup® still on the market, it is no surprise that this tort continues to resurface. As concerns about its effects persist, it’s clear that this litigation may remain a recurring fixture for some time to come.
CPL: $800
CPA: $1333
For criteria, please contact us.
#6 Hernia Mesh – $103,000
Hernia Mesh TV ad spending in December marked the second-lowest monthly spend of 2024 for this tort. Even so, developments in the litigation continue to move forward. A recent joint motion requested a brief extension allowing for the completion of fact discovery before proceeding to the next phase. While the case schedule remains flexible, this tort is a focal point for firms prepared to help plaintiffs seeking resolution.
Common Criteria: Hernia mesh surgery from 2000—current; suffered from one of the following: Perforation, Bowel Obstruction, Mesh Erosion, Mesh Contraction, Torn Mesh, Sepsis/Infection, Granuloma, Adhesion, Dehiscence that resulted in a removal/repair, scheduled or future.
For metrics such as CPA and CPL, please contact us.
#7 AFFF – $15,000
After spiking in November, TV ad spending for AFFF has simmered back down to a lower level in December. Ongoing litigation still keeps this tort in the top ten, particularly as it involves serious claims tied to firefighter health and environmental contamination. This remains a sensitive and significant area for attorneys committed to addressing these important cases.
CPL: $1,750
CPA: $3,500
For criteria, please contact us.
#8 Spinal Cord Stimulator – $12,000
The Spinal Cord Stimulator tort made its debut in this month’s report. These devices, flagged by the FDA for over 80,000 injury reports, rank as one of the most problematic medical devices. These lawsuits often stem from claims involving device malfunctions, implant migrations, surgical issues, or related injuries, highlighting the need for accountability and improved patient safety.
For metrics such as CPA, CPL, and criteria, please contact us.
#9 Birth Injury – $1,000
December 2024 marked the lowest TV ad spending of the year for Birth Injury by far, with a sharp decline compared to previous months. Despite this drop, this tort remains ever-present in the public eye and continues to be a necessary point of legal advocacy. As cases tied to medical errors during childbirth persist, this tort is likely to remain relevant and impactful for years to come.
For metrics such as CPA, CPL, and criteria, please contact us.
#10 9/11 Claims – $1,000
Tied with Birth Injury spending for last place, December saw a marked decrease in TV ad spending for 9/11 Claims. Despite the decrease, this remains profoundly important, addressing the long-term health impacts faced by those exposed to toxins from the events of September 11th, 2001. For firms dedicated to advocating for these victims, the urgency of this litigation cannot be understated.
For metrics such as CPA, CPL, and criteria, please contact us.
